Stay updated on Oral vs Injectable for First-Episode Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page.

Latest updates to the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedA notice about NIH's transition from using “Artificial Intelligence” to “Super Intelligence” appears near the top of the page.SummaryDifference0.7%

- Check19 days agoChange DetectedThe site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page shows a new Revision: v3.7.0 replacing the previous v3.6.6, indicating the study history was updated. This is an administrative revision rather than a change to the trial's content or outcomes.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, indicating a newer site build; this change reflects an update to the site infrastructure rather than to the study information.SummaryDifference0.1%

Stay in the know with updates to Oral vs Injectable for First-Episode Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page.